Enhabit (NYSE:EHAB) Shares Gap Up to $13.50

Enhabit, Inc. (NYSE:EHABGet Rating) gapped up prior to trading on Thursday . The stock had previously closed at $13.50, but opened at $14.18. Enhabit shares last traded at $13.13, with a volume of 5,744 shares.

Wall Street Analysts Forecast Growth

Separately, Bank of America started coverage on Enhabit in a report on Wednesday, July 13th. They issued an “underperform” rating and a $16.00 price target on the stock.

Enhabit Stock Performance

The company has a debt-to-equity ratio of 0.65, a current ratio of 1.41 and a quick ratio of 1.38.

Insider Buying and Selling at Enhabit

In other news, Director Leo I. Higdon, Jr. acquired 4,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 3rd. The shares were bought at an average cost of $13.57 per share, with a total value of $61,065.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at approximately $61,065. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Hedge Funds Weigh In On Enhabit

A hedge fund recently bought a new stake in Enhabit stock. OLD Mission Capital LLC acquired a new stake in shares of Enhabit, Inc. (NYSE:EHABGet Rating) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 16,500 shares of the company’s stock, valued at approximately $379,000.

About Enhabit

(Get Rating)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Read More

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.